Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,086 INR | +0.50% | +8.93% | +57.58% |
05-21 | Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988 | MT |
05-21 | Zydus Lifesciences Records Sharp Rise in Fiscal Q4 Consolidated Profit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.58% | 13.06B | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B | |
-14.88% | 4.27B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets